Balic, M; Posch, F; Bartsch, R. Phase II Study of Neratinib and Trastuzumab plus -oral Vinorelbine in previously treated metastatic Her2 positive Breast Cancer ONCOL RES TREAT. 2022; 45(SUPPL 2): 106-106. [Poster] Web of Science